Rossari Biotech Limited (NSE:ROSSARI)
India · Delayed Price · Currency is INR 560.90
+27.20 (5.10%)
Jun 19, 2026, 3:30 PM IST
Rossari Biotech Stock Forecast
Stock Price Forecast
According to 4 analysts polled by S&P Global, Rossari Biotech stock has a consensus rating of "Buy" and an average price target of ₹601.75. The average 1-year stock price forecast is 7.28% higher than the current stock price, while the lowest is ₹570.00 (+1.62%) and the highest is ₹637.00 (+13.57%).
Price Target: ₹601.75 (+7.28%)
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for Rossari Biotech stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Jun '25 | Jul '25 | Aug '25 | Oct '25 | Jan '26 | Apr '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 2 | 3 | 3 | 3 |
| Buy | 1 | 1 | 1 | 1 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 4 | 4 | 3 | 4 | 4 | 4 |
Financial Forecast
Revenue This Year
26.85B
from 23.96B
Increased by 12.04%
Revenue Next Year
29.73B
from 26.85B
Increased by 10.73%
EPS This Year
28.50
from 26.93
Increased by 5.83%
EPS Next Year
33.55
from 28.50
Increased by 17.72%
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is INR.
Revenue Forecast
| Revenue | 2027 | 2028 |
|---|---|---|
| High | 27.5B | |
| Avg | 26.8B | |
| Low | 26.0B |
Revenue Growth
| Revenue Growth | 2027 | 2028 |
|---|---|---|
| High | 14.8% | |
| Avg | 12.0% | |
| Low | 8.3% |
EPS Forecast
| EPS | 2027 | 2028 |
|---|---|---|
| High | - | |
| Avg | 28.50 | |
| Low | - |
EPS Growth
| EPS Growth | 2027 | 2028 |
|---|---|---|
| High | - | |
| Avg | 5.8% | |
| Low | - |